Literature DB >> 20585956

Epac stimulation induces rapid increases in connexin43 phosphorylation and function without preconditioning effect.

Nicolas Duquesnes1, Mickael Derangeon, Mélanie Métrich, Alexandre Lucas, Philippe Mateo, Lin Li, Eric Morel, Frank Lezoualc'h, Bertrand Crozatier.   

Abstract

It has been recently shown that beta-adrenergic receptors are able to activate phospholipase C via the cyclic adenosine monophosphate-binding protein Epac. This new interconnection may participate in isoproterenol (Iso)-induced preconditioning. We evaluated here whether Epac could induce PKCepsilon activation and could play a role in ischemic preconditioning through the phosphorylation of connexin43 (Cx43) and changes in gap junctional intercellular communication (GJIC). In cultured rat neonatal cardiomyocytes, we showed that in response to Iso and 8-CPT, a specific Epac activator, PKCepsilon content was increased in particulate fractions of cell lysates independently of protein kinase A (PKA). This was associated with an increased Cx43 phosphorylation. Both Iso and 8-CPT induced an increase in GJIC that was blocked by the PKC inhibitor bisindolylmaleimide. Interestingly, inhibition of PKA partly suppressed both Iso-induced increases in Cx43 phosphorylation and in GJIC. The same PKCepsilon-dependent Cx43 phosphorylation by beta-adrenergic stimulation via Epac was found in adult rat hearts. However, in contrast with Iso that induced a preconditioning effect, perfusion of isolated hearts with 8-CPT prior to ischemia failed to improve the post-ischemia functional recovery. In conclusion, Epac stimulation induces PKCepsilon activation and Cx43 phosphorylation with an increase in GJIC, but Epac activation does not induce preconditioning to ischemia in contrast with beta-adrenergic stimulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20585956     DOI: 10.1007/s00424-010-0854-9

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  45 in total

1.  Epac-mediated activation of phospholipase C(epsilon) plays a critical role in beta-adrenergic receptor-dependent enhancement of Ca2+ mobilization in cardiac myocytes.

Authors:  Emily A Oestreich; Huan Wang; Sundeep Malik; Katherine A Kaproth-Joslin; Burns C Blaxall; Grant G Kelley; Robert T Dirksen; Alan V Smrcka
Journal:  J Biol Chem       Date:  2006-12-17       Impact factor: 5.157

2.  The cAMP binding protein Epac regulates cardiac myofilament function.

Authors:  Olivier Cazorla; Alexandre Lucas; Florence Poirier; Alain Lacampagne; Frank Lezoualc'h
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-06       Impact factor: 11.205

3.  Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation.

Authors:  Stephan Weng; Melani Lauven; Thomas Schaefer; Lioudmila Polontchouk; Rajiv Grover; Stefan Dhein
Journal:  FASEB J       Date:  2002-05-08       Impact factor: 5.191

4.  Protein kinase Cepsilon mediates salutary effects on electrical coupling induced by ischemic preconditioning.

Authors:  Thomas J Hund; Deborah L Lerner; Kathryn A Yamada; Richard B Schuessler; Jeffrey E Saffitz
Journal:  Heart Rhythm       Date:  2007-06-08       Impact factor: 6.343

5.  Epac and phospholipase Cepsilon regulate Ca2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin kinase II.

Authors:  Emily A Oestreich; Sundeep Malik; Sanjeewa A Goonasekera; Burns C Blaxall; Grant G Kelley; Robert T Dirksen; Alan V Smrcka
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

6.  Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury.

Authors:  Marisol Ruiz-Meana; Antonio Rodríguez-Sinovas; Alberto Cabestrero; Kerstin Boengler; Gerd Heusch; David Garcia-Dorado
Journal:  Cardiovasc Res       Date:  2007-11-09       Impact factor: 10.787

7.  Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes.

Authors:  Bradley W Doble; Xitong Dang; Peipei Ping; Robert R Fandrich; Barbara E Nickel; Yan Jin; Peter A Cattini; Elissavet Kardami
Journal:  J Cell Sci       Date:  2004-01-26       Impact factor: 5.285

8.  P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis.

Authors:  Motohiro Nishida; Yoji Sato; Aya Uemura; Yusuke Narita; Hidetoshi Tozaki-Saitoh; Michio Nakaya; Tomomi Ide; Kazuhiro Suzuki; Kazuhide Inoue; Taku Nagao; Hitoshi Kurose
Journal:  EMBO J       Date:  2008-11-13       Impact factor: 11.598

9.  Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication.

Authors:  P D Lampe; E M TenBroek; J M Burt; W E Kurata; R G Johnson; A F Lau
Journal:  J Cell Biol       Date:  2000-06-26       Impact factor: 10.539

Review 10.  Remodelling of gap junctions and connexin expression in diseased myocardium.

Authors:  Nicholas J Severs; Alexandra F Bruce; Emmanuel Dupont; Stephen Rothery
Journal:  Cardiovasc Res       Date:  2008-06-02       Impact factor: 10.787

View more
  13 in total

1.  Pituitary adenylate cyclase-activating peptide enhances electrical coupling in the mouse adrenal medulla.

Authors:  Jacqueline Hill; Seong-Ki Lee; Prattana Samasilp; Corey Smith
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-16       Impact factor: 4.249

2.  Epac2-dependent mobilization of intracellular Ca²+ by glucagon-like peptide-1 receptor agonist exendin-4 is disrupted in β-cells of phospholipase C-ε knockout mice.

Authors:  Igor Dzhura; Oleg G Chepurny; Grant G Kelley; Colin A Leech; Michael W Roe; Elvira Dzhura; Parisa Afshari; Sundeep Malik; Michael J Rindler; Xin Xu; Youming Lu; Alan V Smrcka; George G Holz
Journal:  J Physiol       Date:  2010-11-01       Impact factor: 5.182

3.  β-Adrenergic receptors stimulate interleukin-6 production through Epac-dependent activation of PKCδ/p38 MAPK signalling in neonatal mouse cardiac fibroblasts.

Authors:  Chao Chen; Jianhai Du; Wei Feng; Yao Song; Zhizhen Lu; Ming Xu; Zijian Li; Youyi Zhang
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

4.  β3 Adrenoceptor-induced cholinergic inhibition in human and rat urinary bladders involves the exchange protein directly activated by cyclic AMP 1 favoring adenosine release.

Authors:  Isabel Silva; M Teresa Magalhães-Cardoso; Fátima Ferreirinha; Sílvia Moreira; Ana Filipa Costa; Diogo Silva; Cátia Vieira; Miguel Silva-Ramos; Paulo Correia-de-Sá
Journal:  Br J Pharmacol       Date:  2020-02-06       Impact factor: 8.739

5.  Inhibition of connexin 26 by the AMP-activated protein kinase.

Authors:  Ioana Alesutan; Mentor Sopjani; Carlos Munoz; Scott Fraser; Bruce E Kemp; Michael Föller; Florian Lang
Journal:  J Membr Biol       Date:  2011-03-12       Impact factor: 1.843

Review 6.  The role of Epac in the heart.

Authors:  Takayuki Fujita; Masanari Umemura; Utako Yokoyama; Satoshi Okumura; Yoshihiro Ishikawa
Journal:  Cell Mol Life Sci       Date:  2016-08-22       Impact factor: 9.261

7.  Myocardial electrotonic response to submaximal exercise in dogs with healed myocardial infarctions: evidence for β-adrenoceptor mediated enhanced coupling during exercise testing.

Authors:  Carlos L Del Rio; Bradley D Clymer; George E Billman
Journal:  Front Physiol       Date:  2015-02-05       Impact factor: 4.566

8.  Functional and cardioprotective effects of simultaneous and individual activation of protein kinase A and Epac.

Authors:  Igor Khaliulin; Mark Bond; Andrew F James; Zara Dyar; Raheleh Amini; Jason L Johnson; M-Saadeh Suleiman
Journal:  Br J Pharmacol       Date:  2017-02-14       Impact factor: 8.739

Review 9.  Epac Function and cAMP Scaffolds in the Heart and Lung.

Authors:  Marion Laudette; Haoxiao Zuo; Frank Lezoualc'h; Martina Schmidt
Journal:  J Cardiovasc Dev Dis       Date:  2018-02-03

10.  Suppression of Rap1 impairs cardiac myofibrils and conduction system in zebrafish.

Authors:  Wei Dong; Zhenglin Yang; Fan Yang; Jialiang Wang; Yan Zhuang; Chongren Xu; Bo Zhang; Xiao-Li Tian; Dong Liu
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.